CLINDAHEXAL Capsule Ref.[50558] Active ingredients: Clindamycin

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2022  Publisher: Sandoz SA (Pty) Ltd<sup>1</sup>, Waterfall 5-lr, Magwa Crescent West, Waterfall City, Jukskei View, 2090 1 Company Reg. No.: 1990/001979/07

Product name and form

CLINDAHEXAL150 (capsules).

CLINDAHEXAL 300 (capsules).

Pharmaceutical Form

CLINDAHEXAL 150: Opaque brown/red-brown hard gelatine capsules, size 1, filled with homogenous powder.

CLINDAHEXAL 300: Opaque brown hard gelatine capsules, size 0, filled with homogenous powder.

Qualitative and quantitative composition

Each CLINDAHEXAL 150 capsule contains: clindamycin hydrochloride equivalent to 150 mg clindamycin base.

Each CLINDAHEXAL 300 capsule contains: clindamycin hydrochloride equivalent to 300 mg clindamycin base.

Each CLINDAHEXAL 150 mg capsule contains sugar (78,80 mg lactose monohydrate).

Each CLINDAHEXAL 300 mg capsule contains sugar (157,60 mg lactose monohydrate).

Active Ingredient Description
Clindamycin

Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.

List of Excipients

Lactose monohydrate, magnesium stearate, pregelatinised maize starch, talc.

The hard gelatine capsules are composed of: Black iron oxide (E172), gelatine, red iron oxide (E172), titanium dioxide (E171), yellow iron oxide (E172).

Pack sizes and marketing

White opaque PVC/Aluminium blisters containing 10 capsules each. 2 (10) blister strips to be packed into a carton i.e. 20 capsules per carton or 10 (10) blister strips to be packed into a carton i.e. 100 capsules per carton, or

White Polypropylene securitainers containing 20 or 100 capsules.

Not all packs may be marketed.

Marketing authorization holder

Sandoz SA (Pty) Ltd1, Waterfall 5-lr, Magwa Crescent West, Waterfall City, Jukskei View, 2090

1 Company Reg. No.: 1990/001979/07

Marketing authorization dates and numbers

CLINDAHEXAL 150: 32/20.1.1/0038
CLINDAHEXAL 300: 32/20.1.1/0039

Date of first authorisation:

CLINDAHEXAL 150 mg: 29 March 1999
CLINDAHEXAL 300 mg: 15 February 2000

Drugs

Drug Countries
CLINDAHEXAL Germany, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.